Paul Quinlan | General Counsel |
Sujal Shah | President and Chief Executive Officer |
Harish Shantharam | Chief Financial Officer |
Charles McWherter | Chief Scientific Officer and President of Research and Development |
Lewis Stuart | Chief Commercial Officer |
Yasmeen Rahimi | Piper Sandler |
Steve Seedhouse | Raymond James |
Kristen Kluska | Cantor Fitzgerald |
Patrick Dolezal | LifeSci Capital |
Julian Harrison | BTIG |
Jay Olson | Oppenheimer |
Ed Arce | H.C. Wainwright |
Thomas Smith | Leerink Partners |
Mayank Mamtani | B. Riley |
Good day, ladies and gentlemen, and welcome to CymaBay’s Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company’s request. It is also being webcast live on the Investors section at the CymaBay website at www.cymabay.com.